期刊文献+

C反应蛋白对冠心病的应用价值 被引量:1

The Applied Value of C-Reactive Protein in Coronary Artery Disease
下载PDF
导出
摘要 目的 :探讨 C反应蛋白 (CRP)测定在冠心病中的应用价值。方法 :测定 1 0 6例冠心病患者和 1 0 6例与之性别、年龄相匹配的正常对照者的 CRP、白细胞 (WBC)、纤维蛋白原 (FIB)及血脂水平 ,记录吸烟史、高血压病及糖尿病史 ,并计算体重指数 (BMI)。其中冠心病组又分为 3组 ,急性心肌梗死 (AMI)组 2 6例 ,不稳定心绞痛 (UAP)组 4 1例 ,SAP(稳定性心绞痛 )组 39例。比较冠心病组各组间及与对照组之间 CRP等的差异。结果 :冠心病组 CRP和 WBC水平高于对照组 (P分别为 0 .0 0 9和 0 .0 1 7) ,经调整性别、年龄、 BMI、吸烟史、高血压病及糖尿病史、血脂指标后 ,CRP和WBC水平仍与冠心病患病率显著相关 ,OR分别为 1 .72 6和 1 .4 70 (P分别为 0 .0 4 8和 0 .0 36 )。 AMI组及 UAP组CRP水平与对照组相比有显著性差异 (P=0 .0 34,P<0 .0 0 1 ) ;U AP组与 SAP组相比 ,CRP水平也有显著性差异 (P=0 .0 1 1 ) ;而 SAP组与对照组相比 CRP水平则无明显差异 (P>0 .0 5 )。结论 :CRP水平升高是冠心病的独立危险因素。 Objective:To assess the applied value of C-Reactive Protein(CRP) in Coronary Artery Disease(CAD) Methods:The level of CRP, white blood cell (WBC),fibrinogen(FIB) and serum lipid in 106 patients with CAD and 106 healthy controls matched with CAD patients for sex and age range were assessed The body mass index(BMI) from patients' weight and height were computed The patient history inquiring about smoking habits,diabetes and hypertension were taken from every patient The patients with CAD were divided into three groups,26 cases of acute mycocardial infarction(AMI group),41 cases of unstable angina pectoris (UAP group),39 cases of stable angina pectoris(SAP group) The level of CRP,FIB WBC and serum lipid in three subgroups with that in controls were compared Results:The level of CRP and WBC in CAD group were higher than those in control group After adjuted for sex,age,BMI,smoking habits,diabetes,hypertension and serum lipid,CRP was correlated with CAD,the Odds Radio were 1 726 and 1 470 The levels of CRP in AMI group and UAP group were higher than that in control group The level of CRP in UAP group was higher than that in SAP group too There was no significant difference in the level of CRP between SAP group and control group Conclusion:Elevated CRP is an independent risk factor for CAD The level of CRP can reflect the disease degree in patients with CAD
出处 《华夏医学》 2003年第4期458-460,共3页 Acta Medicinae Sinica
关键词 C反应蛋白 冠心病 发病机制 C-reactive protein coronary artery disease
  • 相关文献

参考文献8

  • 1[1]Maseri A.Inflammation,altherosclerosis,and ischemic events-exploring the hidden side of the moon[J].N Engl J Med,1997,336:1014-1016.
  • 2[2]Anderson J L,Carlquist J F,Muhlestein J B,et al.Evalution of C-reactive protein,an inflammatory marker,and infectious seroiogy as risk factors for coronary artery disease and myocardial infarction[J].J AM coll Cardiol,1998,32:35-41.
  • 3[3]Zhu J, Quyyumi A A,Norman J E,et al.Cytomegalovirus in the pathogenesis of atherosclerosis:the role of inflammation as reflected by elevated C-reactive protion levels[J].J Am Coll cardiol,1999,34:1738-1743.
  • 4[4]Muhlestein J B,Horne B D,Carlquist J F,et al.Cytomegalovirus seropositivitv and C-reactive protein have independent and combined predictive value for mortalitv in patients with angiographically demonstrated coronary artery disease[J].circulation,2000,102:1917-1923.
  • 5[5]Cavusoglu Y,Gorenek B,Alpsoy S,et al.Evaluation of C-reactive protein,fibrinogen and antithrombin-Ⅲ as risk factors for coronary artery disease[J].Isr-Med-Assoc-J,2001,3:13-16.
  • 6[6]Morrow DA,Rifai N,Antman EM,et al.C-reactive protein is a potent predictor of mortalitv independently of and in comdination with troponinT in acute coronary syndromes:a TIMI 11A substudy.Thrombolysis in Myocardial Infarction[J].J Am Coll Cardiol,1998,31:1460-1465.
  • 7[7]Torzewski J,Torzewski M,Bowyer D E,et al.C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries[J].Arterioscler Thromb Vasc Biol,1998,18:1386-1392.
  • 8[8]Hatanakak,Li X A,Masuda K,et al.Immunohistochemical localization of C-reactive protein binding sites in human aortic lesions by a modified streptavidin-biotinstaining method[J].Pathol Int,1995,45:631-641.

同被引文献11

  • 1韩纪举,任道凌,李震,吴亚平,王增贤,陈彬,魏然.冠心病患者血浆血管性假血友病因子及其前肽水平与血管内皮损伤的关系[J].中国临床康复,2004,8(30):6606-6608. 被引量:7
  • 2张雪莲,傅汉菁,潘素芳.糖尿病慢性大血管并发症与vWF的关系[J].首都医科大学学报,2004,25(4):488-492. 被引量:8
  • 3LIP G Y, BLANN A D. Von Willcbrand factor and its relevance to cardiovascular disorder [ J]. Br Heart J, 1995, 74 (6) : 580 - 583.
  • 4GALATIUS S, WROBLEWSKI H, SORENSEN V B, et al. Endothelin and Von - willebrand factor as parameters of endothelial function in idiopataic dilated cardiomyopathy: different stimuli for release before and after heart transplantation [ J ]. Am Heart J, 1999,137(3) : 549 -554.
  • 5BLANN A D, NAQUI T, WAITE M, et al. Von - willebrand factor and andothelial damage inessential hypertension [ J ]. J Hum Hyertens,1993, 7: 107.
  • 6FICHTLSCHERER S, ROSENBERER G, DIRK H, et al. Elevated C - reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease [ J ]. Circulation, 2000, 102 : 1 000 - 1 006.
  • 7VALLANCE P, COLLIER J, BHAGAT K. Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link? [J]. Lancet, 1997, 349:1 391 -1 392.
  • 8BHGAT K, VALANCE P. Inflammatory cytokines impair endothelium dependent dilation in human veins in vivo[ J]. Circulation, 1997, 96 : 3 042 - 3 047.
  • 9HAYAISHI OKANO R, YAMASAKI Y, KATAKAMI N, et al. Elevated C - reaactive protein associates with early stage carotid atherosclerosis in young subjects with type 1 diabetes[ J] . Diabetes Care, 2002, 25 : 1 432 - 1 438.
  • 10王骏,王鸣和,范维琥.动脉粥样硬化的形成与消退[J].心血管病学进展,1999,20(5):257-260. 被引量:20

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部